In line, a trend towards higher expressions of COL6A1, F2R, and ITGA2 was seen in the blast phase CML compared to samples at initial diagnosis (Fig. S10C). The gene discussed is ITGA2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.